Brief: Ferring International Center And Scivac, Subsidiary Of VBI Vaccines Inc, Amended And Restated License Agreement
20/10/2022 13:54
Oct 20 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES INC - ON OCT 18, FERRING INTERNATIONAL CENTER
AND
SCIVAC , A WHOLLY-OWNED SUBSIDIARY OF CO, AMENDED AND RESTATED
LICENSE AGREEMENT
* VBI VACCINES INC - AGREEMENT AMENDS AND RESTATES CERTAIN
TERMS
RELATING TO THE MANUFACTURE AND MARKETING OF HBSAG PRODUCTS OF
CO
* VBI VACCINES INC - AGREEMENT UPDATES REDUCTION IN THE
FIXED
ROYALTY RATE ON NET SALES OF HBSAG PRODUCTS FROM 7% TO 3.5%
* VBI VACCINES INC - AGREED TO ACT AS THE GUARANTOR FOR
SCIVAC’S
OBLIGATIONS UNDER THE FERRING LICENSE AGREEMENT
Source: (shorturl.at/ftuJM)
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55